A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
Clinical trial NCT02623465 · WITHDRAWN
Trial details
- NCT number
- NCT02623465
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2018-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.